Furthermore, it addresses the FDA’s communications with the applicant, the retention of records that help the SE report, confidentiality of an SE report, how an applicant can amend or withdraw an SE report, how an applicant might transfer ownership of an SE report to a fresh applicant and electronic submission of your SE report and amendments.imp